3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Breast Neoplasms
2
Anatomic Stage III Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Renal Insufficiency, Chronic
1
Prostatic Neoplasms
1
Pleuropulmonary blastoma
1
Pain
1
Neuroblastoma
1
Melanoma
1
Leukemia, Hairy Cell
1
Ganglioneuroblastoma
1
Carcinoma, Renal Cell
1
Carcinoma, Medullary
1
Carcinoma, Intraductal, Noninfiltrating
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Interventions
Cyclophosphamide
48
fludarabine
32
Methotrexate
24
blinatumomab
20
fludarabine phosphate
19
Dexamethasone
19
Vincristine
18
Whole-Body Irradiation
16
Specimen Handling
16
Cytarabine
16
Tacrolimus
14
Mycophenolic Acid
14
Peripheral Blood Stem Cell Transplantation
13
Melphalan
13
Mercaptopurine
12
Calcium Dobesilate
12
merphos
11
Busulfan
11
Biopsy
11
Magnetic Resonance Spectroscopy
10
Etoposide
10
Stem Cell Transplantation
9
Prednisone
9
Granulocyte Colony-Stimulating Factor
9
Cyclosporine
9
Thiotepa
8
Rituximab
8
Mesna
8
Filgrastim
8
Doxorubicin
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
High-Energy Shock Waves
×
90 days
×
Clear all
No trials found.